NYAX:NASDAQNayax Ltd. Analysis
Data as of 2026-05-19 - not real-time
$63.78
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Technical outlook: The stock is trading just above a key support level while the short‑term moving average sits above the mid‑term average, indicating a bullish bias. However, the MACD histogram is negative and the MACD line trails its signal, suggesting weakening momentum. The RSI hovers in the neutral zone, and volume has been on an upward trend, adding weight to the bullish directional bias but also warning of possible volatility ahead.
Fundamental and news drivers: Recent results showed robust revenue expansion and a modest improvement in profitability, and management has reaffirmed its full‑year guidance, reinforcing confidence in the growth narrative. The company is actively engaging the market through a major industry conference, which should help broaden its merchant base. Nevertheless, valuation metrics are stretched—price‑to‑earnings is markedly higher than the sector average and a discounted cash‑flow model places intrinsic value well below the current price—while the balance sheet shows a high leverage ratio and no dividend, highlighting valuation and financial risk.
Fundamental and news drivers: Recent results showed robust revenue expansion and a modest improvement in profitability, and management has reaffirmed its full‑year guidance, reinforcing confidence in the growth narrative. The company is actively engaging the market through a major industry conference, which should help broaden its merchant base. Nevertheless, valuation metrics are stretched—price‑to‑earnings is markedly higher than the sector average and a discounted cash‑flow model places intrinsic value well below the current price—while the balance sheet shows a high leverage ratio and no dividend, highlighting valuation and financial risk.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bearish MACD momentum
- Price near technical support
- Elevated valuation multiples
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Sustained revenue growth
- Improving operating cash flow
- Continued high valuation relative to peers
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Strong top‑line growth trajectory
- Expanding market presence via industry events
- Potential for valuation compression as earnings catch up
Key Metrics & Analysis
Financial Health
Revenue Growth31.70%
Profit Margin6.96%
P/E Ratio79.7
ROE14.24%
ROA2.94%
Debt/Equity142.01
P/B Ratio10.3
Op. Cash Flow$42.6M
Free Cash Flow$-19348376
Industry P/E38.2
Technical Analysis
TrendBullish
RSI44.1
Support$61.70
Resistance$74.83
MA 20$68.40
MA 50$62.68
MA 200$52.26
MACDBearish
VolumeIncreasing
Fear & Greed Index89.36
Valuation
Fair Value$27.52
Target Price$76.95
Upside/Downside20.65%
GradeOvervalued
TypeGrowth
Risk Assessment
Beta0.83
Volatility47.39%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.